Phasic dopamine neuron activity elicits unique mesofrontal plasticity in adolescence

J Neurosci. 2014 Jul 16;34(29):9484-96. doi: 10.1523/JNEUROSCI.1114-14.2014.

Abstract

The mesofrontal dopaminergic circuit, which connects the midbrain motivation center to the cortical executive center, is engaged in control of motivated behaviors. In addition, deficiencies in this circuit are associated with adolescent-onset psychiatric disorders in humans. Developmental studies suggest that the mesofrontal circuit exhibits a protracted maturation through adolescence. However, whether the structure and function of this circuit are modifiable by activity in dopaminergic neurons during adolescence remains unknown. Using optogenetic stimulation and in vivo two-photon imaging in adolescent mice, we found that phasic, but not tonic, dopamine neuron activity induces the formation of mesofrontal axonal boutons. In contrast, in adult mice, the effect of phasic activity diminishes. Furthermore, our results showed that dopaminergic and glutamatergic transmission regulate this axonal plasticity in adolescence and inhibition of dopamine D2-type receptors restores this plasticity in adulthood. Finally, we found that phasic activation of dopamine neurons also induces greater changes in mesofrontal circuit activity and psychomotor response in adolescent mice than in adult mice. Together, our findings demonstrate that the structure and function of the mesofrontal circuit are modifiable by phasic activity in dopaminergic neurons during adolescence and suggest that the greater plasticity in adolescence may facilitate activity-dependent strengthening of dopaminergic input and improvement in behavioral control.

Keywords: adolescence; dopamine; frontal cortex; in vivo imaging; optogenetics; phasic activity.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / genetics
  • Age Factors
  • Amphetamine / pharmacology
  • Animals
  • Animals, Newborn
  • Dextrans / pharmacokinetics
  • Dopamine Agents / pharmacology
  • Dopaminergic Neurons / physiology*
  • Excitatory Amino Acid Agents / pharmacology
  • Frontal Lobe / cytology*
  • Frontal Lobe / metabolism
  • Gene Expression Regulation, Developmental / drug effects
  • Gene Expression Regulation, Developmental / genetics
  • Gene Expression Regulation, Developmental / physiology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Motor Activity / drug effects
  • Motor Activity / genetics
  • Neural Pathways / physiology
  • Neuronal Plasticity / genetics
  • Neuronal Plasticity / physiology*
  • Psychomotor Performance / physiology
  • Rhodamines / pharmacokinetics
  • Tyrosine 3-Monooxygenase / genetics
  • Ventral Tegmental Area / cytology*
  • Ventral Tegmental Area / metabolism

Substances

  • Dextrans
  • Dopamine Agents
  • Excitatory Amino Acid Agents
  • Fluoro-Ruby
  • Rhodamines
  • Amphetamine
  • Tyrosine 3-Monooxygenase